Cargando…

From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)

SIMPLE SUMMARY: In Bacillus Calmette–Guérin (BCG) refractory non-muscle-invasive bladder cancer (NMIBC), radical cystectomy is the gold standard. The advent of immune checkpoint inhibitors (CPI) has permanently changed the therapy landscape of bladder cancer (BC). Immune-modulating (IM) therapies ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deininger, Susanne, Törzsök, Peter, Mitterberger, Michael, Pallauf, Maximilian, Oswald, David, Deininger, Christian, Lusuardi, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833656/ https://www.ncbi.nlm.nih.gov/pubmed/35158964 http://dx.doi.org/10.3390/cancers14030694

Ejemplares similares

Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
por: Deininger, Susanne, et al.
Publicado: (2021)

Electrosurgery or laser for benign prostatic enlargement: trumpcard or pitfalls
por: Pallauf, Maximilian, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis
por: Oswald, David, et al.
Publicado: (2022)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
por: Cooper, Owen Alan Edwards, et al.
Publicado: (2023)

On the black slope: analysis of the course of a blunt renal trauma collective in a winter sports region
por: Deininger, Christian, et al.
Publicado: (2021)

Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2023)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
por: Al-Hammadi, Suleiman, et al.
Publicado: (2017)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)
por: Steinberg, Gary, et al.
Publicado: (2015)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Goldilocks and the BCG: Bacillus Calmette-Guérin Dose Reduction in the Age of Shortage
por: Nikas, Christine V., et al.
Publicado: (2020)

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
por: Steinberg, Gary D, et al.
Publicado: (2014)

Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy
por: Afonso, Raquel, et al.
Publicado: (2022)

Long-Term Follow-Up after Testicular Torsion: Prospective Evaluation of Endocrine and Exocrine Testicular Function, Fertility, Oxidative Stress and Erectile Function
por: Törzsök, Peter, et al.
Publicado: (2022)

Renal Arteriovenous (AV) Fistula after High-Grade Blunt Renal Trauma Caused by Traffic Accidents
por: Deininger, Susanne, et al.
Publicado: (2023)

Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)
por: Farah, Naim B, et al.
Publicado: (2014)

The Diagnostic Value of the Added MR Imaging of the Scrotum in the Preoperative Workup of Sonographically Indeterminate Testicular Lesions—A Retrospective Multicenter Analysis
por: Deininger, Susanne, et al.
Publicado: (2022)

Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance
por: Cernuschi, Tania, et al.
Publicado: (2018)

Microbic Dissociation; with Reference to the Attenuated Tubercle Bacillus of Calmette and Guerin (B.C.G.)
por: Begbie, R. S.
Publicado: (1931)

Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy
por: Tsukada, Hiroyuki, et al.
Publicado: (2017)

The Bacillus Calmette-Guérin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Yassen, Asaad Q., et al.
Publicado: (2020)

Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis
por: Mahasha, Phetole Walter, et al.
Publicado: (2019)

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
por: Kawai, Akihito, et al.
Publicado: (2022)

Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation: A case report
por: Moussa, M., et al.
Publicado: (2018)

Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy
por: Güven, Alper Tuna, et al.
Publicado: (2023)

Die chirurgische Therapie der benignen Prostataobstruktion (BPO) beim antikoagulierten Patienten: eine Übersichtsarbeit über die Blutungsrisiken etablierter Techniken
por: Deininger, S., et al.
Publicado: (2020)

Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
por: Pryor, K., et al.
Publicado: (1995)

Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
por: Sampaio, Paula Cíntia Machado, et al.
Publicado: (2017)

Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
por: Berg, Martha K., et al.
Publicado: (2020)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
por: Gofrit, Ofer N., et al.
Publicado: (2019)

Case Reports of Bacillus Calmette-Guérin (BCG) Osteomyelitis: A Rare Complication in Immunocompetent Infants
por: Ghoweba, Yousra, et al.
Publicado: (2020)

Re: The Bacillus Calmette-Guerin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Mendalawi, Mahmood D.
Publicado: (2021)

Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2020)

Bacillus of Calmette and Guérin (BCG) and the risk of leprosy in Ciudad del Este, Paraguay, 2016–2017
por: Cuevas, Nancy Carolina, et al.
Publicado: (2021)

Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma
por: Martinez-Thomas, Jose M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nudieccchaogftrs79uo3ikd8e